Mauro Alaibac

Author PubWeight™ 40.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dermoscopic changes in melanocytic naevi in children during digital follow-up. Acta Derm Venereol 2012 1.99
2 Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 2006 1.70
3 Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol 2012 1.41
4 Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol 2006 1.22
5 Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol 2010 1.15
6 Immunosuppression and melanocyte proliferation. Melanoma Res 2009 1.12
7 Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology 2009 1.03
8 A case of malignant melanoma arising from an acquired agminated melanocytic naevus. Acta Derm Venereol 2007 1.02
9 Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004 0.92
10 Primary cutaneous mantle cell lymphoma. Acta Derm Venereol 2011 0.91
11 Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas. Cancer 2012 0.87
12 Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Acta Derm Venereol 2009 0.87
13 Occurrence of squamous cell carcinoma in an area of lichen simplex chronicus: case report and pathogenetic hypothesis. J Cutan Med Surg 2012 0.85
14 The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem 2010 0.84
15 Imiquimod for the treatment of classical Kaposi's sarcoma. Acta Derm Venereol 2010 0.84
16 Targeting DSG3: from pemphigus to squamous cell carcinoma. Expert Opin Ther Targets 2013 0.84
17 Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep 2011 0.83
18 Bullous scabies simulating pemphigoid. J Cutan Med Surg 2011 0.83
19 Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol 2008 0.82
20 Effectiveness of different substrate materials for in vitro sunscreen tests. J Dermatol Sci 2009 0.82
21 Biochip technology for the serological diagnosis of bullous pemphigoid. ISRN Dermatol 2012 0.81
22 Nevus spilus and melanoma: case report and review of the literature. J Cutan Med Surg 2010 0.81
23 Melanoma in skin affected with keratoderma palmoplantaris hereditaria (Mal de Meleda): Treatment with excision and grafting. J Am Acad Dermatol 2009 0.81
24 Large plaque type blue nevus with subcutaneous cellular nodules. Eur J Dermatol 2009 0.81
25 Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol 2009 0.81
26 Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol Rep 2006 0.80
27 Verrucous cutaneous sarcoidosis in an adolescent with dark skin. Eur J Dermatol 2010 0.80
28 C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int 2005 0.79
29 Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer 2002 0.79
30 Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol 2006 0.79
31 Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. Mutat Res 2009 0.78
32 Melanoma m (zero): diagnosis and therapy. ISRN Dermatol 2013 0.78
33 Sunscreen tests: correspondence between in vitro data and values reported by the manufacturers. J Dermatol Sci 2008 0.78
34 Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol 2009 0.78
35 Skin disorders in patients transplanted in childhood. Transpl Int 2005 0.77
36 Non-alcoholic fatty liver disease, alcohol intake and psoriasis. J Hepatol 2010 0.77
37 In vitro evaluation of sunscreens: an update for the clinicians. ISRN Dermatol 2012 0.77
38 Erosive pustular dermatosis of the scalp induced by imiquimod. Case Rep Dermatol Med 2012 0.77
39 Melanoma m1: diagnosis and therapy. In Vivo 2014 0.77
40 γδ T cells as potential contributors to the progression of parapsoriasis to mycosis fungoides. Mol Med Rep 2011 0.76
41 Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost 2015 0.76
42 Melanoma and immunosuppression. Dermatology 2008 0.76
43 Achromic superficial spreading melanoma accidentally treated with imiquimod. Acta Derm Venereol 2012 0.76
44 Erythroderma in the era of biological therapies. Eur J Dermatol 2012 0.75
45 An unusual association between erosive hand osteoarthritis and morphea. Joint Bone Spine 2011 0.75
46 Clinical and dermoscopic features of nevi in preschool children in Padua. Dermatology 2009 0.75
47 Adaptive immune responses in primary cutaneous sarcoidosis. Clin Dev Immunol 2011 0.75
48 Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma: A Single-center Retrospective Analysis. Medicine (Baltimore) 2016 0.75
49 Response to “change in dermoscopic pattern of naevi in children” by Scope et al. Acta Derm Venereol 2014 0.75
50 Clinical tip: use of a manual dermatoscope with a compact digital camera in a pigmented lesion clinic. Skin Res Technol 2009 0.75
51 Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis. Eur J Dermatol 2012 0.75
52 Exacerbation of a Primary Follicular Centre Cutaneous B-cell Lymphoma during Pregnancy and Resolution to Anetoderma After Delivery. Acta Derm Venereol 2016 0.75
53 Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant 2009 0.75
54 Porokeratosis ptychotropica. Eur J Dermatol 2011 0.75
55 A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate. Acta Derm Venereol 2017 0.75
56 Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α. Melanoma Res 2012 0.75
57 Pustular eruption associated with granulocyte colony-stimulating factor treatment. G Ital Dermatol Venereol 2016 0.75
58 Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers. Eur J Dermatol 2011 0.75
59 Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy. Pigment Cell Melanoma Res 2011 0.75
60 TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going? Immunotherapy 2013 0.75
61 Rejection-mediated regression of melanocytic naevi in an immunosuppressed organ transplant recipient. Acta Derm Venereol 2014 0.75
62 High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma. J Am Acad Dermatol 2005 0.75
63 Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. J Dermatol Sci 2013 0.75
64 Eczematous, Pruritic, Brownish Plaque of the Nipple and Areola: A Quiz. Acta Derm Venereol 2019 0.75
65 Acne keloidalis of the scalp in a renal transplant patient treated with cyclosporine. Acta Derm Venereol 2009 0.75
66 Analysis of immunoglobulin variable kappa gene mutations in cutaneous B-cell lymphoma. J Dermatol Sci 2007 0.75
67 Squamous cell carcinoma. Cancer Treat Res 2009 0.75
68 Analysis of p53 polymorphisms in individuals with multiple melanocytic nevi. Eur J Dermatol 2013 0.75
69 Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease. Melanoma Res 2005 0.75
70 Effects of TNF-alpha inhibitors on the number of epidermal Langerhans cells in uninvolved skin of psoriatic patients: a pilot study. Acta Histochem 2013 0.75